231 related articles for article (PubMed ID: 10219883)
1. Long-term monitoring of rec-GH treatment by serial determination of serum aminoterminal propeptide of type III procollagen in children and adults with GH deficiency.
Sartorio A; Arosio M; Conti A; Ferrero S; Porretti S; Faglia G
J Endocrinol Invest; 1999 Mar; 22(3):169-75. PubMed ID: 10219883
[TBL] [Abstract][Full Text] [Related]
2. Effects of 12 months rec-GH therapy on bone and collagen turnover and bone mineral density in GH deficient children with thalassaemia major.
Sartorio A; Conte G; Conti A; Masala A; Alagna S; Rovasio P; Faglia G
J Endocrinol Invest; 2000 Jun; 23(6):356-61. PubMed ID: 10908162
[TBL] [Abstract][Full Text] [Related]
3. [Effect of GH/IGF-I deficiency on bone and collagen turnover in children and adults with GH deficiency].
Sartorio A; Conti A; Monzani M; Ferrero S; Biella O; Casati G; Faglia G
Minerva Endocrinol; 1995 Jun; 20(2):135-40. PubMed ID: 8531895
[TBL] [Abstract][Full Text] [Related]
4. New markers of bone and collagen turnover in children and adults with growth hormone deficiency.
Sartorio A; Conti A; Monzani M
Postgrad Med J; 1993 Nov; 69(817):846-50. PubMed ID: 8290428
[TBL] [Abstract][Full Text] [Related]
5. Effects of 12-month GH treatment on bone metabolism and bone mineral density in adults with adult-onset GH deficiency.
Sartorio A; Ortolani S; Galbiati E; Conte G; Vangeli V; Arosio M; Porretti S; Faglia G
J Endocrinol Invest; 2001 Apr; 24(4):224-30. PubMed ID: 11383908
[TBL] [Abstract][Full Text] [Related]
6. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone treatment in adults with GH deficiency: effects on new biochemical markers of bone and collagen turnover.
Sartorio A; Conti A; Monzani M; Morabito F; Faglia G
J Endocrinol Invest; 1993 Dec; 16(11):893-8. PubMed ID: 8144866
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency.
Bollerslev J; Møller J; Thomas S; Djøseland O; Christiansen JS
Eur J Endocrinol; 1996 Dec; 135(6):666-71. PubMed ID: 9025710
[TBL] [Abstract][Full Text] [Related]
9. Elite volunteer athletes of different sport disciplines may have elevated baseline GH levels divorced from unaltered levels of both IGF-I and GH-dependent bone and collagen markers: a study on-the-field.
Sartorio A; Marazzi N; Agosti F; Faglia G; Corradini C; De Palo E; Cella S; Rigamonti A; Muller EE
J Endocrinol Invest; 2004 May; 27(5):410-5. PubMed ID: 15279071
[TBL] [Abstract][Full Text] [Related]
10. Thymulin, zinc and insulin-like growth factor-I (IGF-I) activity before and during recombinant growth hormone (rec-GH) therapy in children and adults with GH deficiency.
Mocchegiani E; Sartorio A; Santarelli L; Ferrero S; Fabris N
J Endocrinol Invest; 1996 Oct; 19(9):630-7. PubMed ID: 8957749
[TBL] [Abstract][Full Text] [Related]
11. Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients.
Longobardi S; Di Rella F; Pivonello R; Di Somma C; Klain M; Maurelli L; Scarpa R; Colao A; Merola B; Lombardi G
J Endocrinol Invest; 1999 May; 22(5):333-9. PubMed ID: 10401706
[TBL] [Abstract][Full Text] [Related]
12. Collagen metabolites in the prediction of response to GH therapy in short children.
Tapanainen P; Knip M; Risteli L; Kemppainen L; Käär ML; Risteli J
Eur J Endocrinol; 1997 Dec; 137(6):621-5. PubMed ID: 9437226
[TBL] [Abstract][Full Text] [Related]
13. Intestinal calcium absorption and bone metabolism in young adult men with childhood-onset growth hormone deficiency.
de Boer H; Blok GJ; Popp-Snijders C; Sips A; Lips P; van der Veen E
J Bone Miner Res; 1998 Feb; 13(2):245-52. PubMed ID: 9495517
[TBL] [Abstract][Full Text] [Related]
14. Serum aminoterminal propeptide of type III procollagen: a potential predictor of the response to growth hormone therapy.
Tapanainen P; Risteli L; Knip M; Käär ML; Risteli J
J Clin Endocrinol Metab; 1988 Dec; 67(6):1244-9. PubMed ID: 3192681
[TBL] [Abstract][Full Text] [Related]
15. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.
Magnusson P; Degerblad M; Sääf M; Larsson L; Thorén M
J Bone Miner Res; 1997 Feb; 12(2):210-20. PubMed ID: 9041052
[TBL] [Abstract][Full Text] [Related]
16. Modifications of biochemical markers of bone and collagen turnover during corticosteroid therapy.
Conti A; Sartorio A; Ferrero S; Ferrario S; Ambrosi B
J Endocrinol Invest; 1996 Feb; 19(2):127-30. PubMed ID: 8778165
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults--an 18-month randomised, placebo-controlled, double blinded trial.
Sneppen SB; Hoeck HC; Kollerup G; Sørensen OH; Laurberg P; Feldt-Rasmussen U
Eur J Endocrinol; 2002 Feb; 146(2):187-95. PubMed ID: 11834427
[TBL] [Abstract][Full Text] [Related]
18. [Long-term effects of 7-year growth hormone substitution on bone metabolism, bone density, and bone quality in growth hormone-deficient adults].
Wilhelm B; Kann PH
Med Klin (Munich); 2004 Oct; 99(10):569-77. PubMed ID: 15490072
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group.
Longobardi S; Keay N; Ehrnborg C; Cittadini A; Rosén T; Dall R; Boroujerdi MA; Bassett EE; Healy ML; Pentecost C; Wallace JD; Powrie J; Jørgensen JO; Saccà L
J Clin Endocrinol Metab; 2000 Apr; 85(4):1505-12. PubMed ID: 10770189
[TBL] [Abstract][Full Text] [Related]
20. Twenty-four-hour osteocalcin, carboxyterminal propeptide of type I procollagen, and aminoterminal propeptide of type III procollagen rhythms in normal and growth-retarded children.
Saggese G; Baroncelli GI; Bertelloni S; Cinquanta L; DiNero G
Pediatr Res; 1994 Apr; 35(4 Pt 1):409-15. PubMed ID: 8047377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
